FDA approval for Lilly’s weekly insulin Onswik, shares dip
Onswik FDA approval: Eli Lilly's once-weekly insulin wins US clearance for type 2 diabetes, but LLY shares slipped on the day.
Topic
FDA approval
Every Financial News story tagged FDA approval, newest first.
- Stories
- 7
- Last updated
- Follow
- RSS feed
Pfizer wins FDA approval for Talzenna-Xtandi in earlier prostate cancer
Talzenna Xtandi FDA approval moves Pfizer's prostate cancer combination into earlier-stage treatment, backed by a 52% risk-reduction trial result.
FDA Approves Ionis’s Zanvastro for Alexander Disease
FDA approves Zanvastro, the first Alexander disease treatment, from Ionis Pharmaceuticals - but shares barely move on the news.
More in FDA approval
1–7 of 7
Revolution Medicines Wins FDA Pancreatic Cancer Drug Approval
The FDA's pancreatic cancer drug approval for Revolution Medicines' daraxonrasib lands months early, but the stock barely moved. Here's why.
FDA authorises Abbott’s Libre Duo dual glucose-ketone sensor
Abbott's Libre Duo 10 Day wins FDA authorisation as the first dual glucose-ketone sensor, opening a new front in diabetes-tech competition.
Alesi Surgical’s £5m Funding Boost for Global Expansion
Alesi Surgical, a Cardiff-based medtech company, is poised for significant global expansion following a successful £5 million equity increase led by Mercia Ventures.The company specialises in technology that mitigates the…
neuroClues Achieves €5M Funding for Neurological Diagnostic Technology
neuroClues, a leading medtech startup, has secured €5 million in its latest funding initiative. This development aims to enhance their innovative eye-tracking technology.Eye movements reveal underlying neurological disorders, and neuroClues…
